Pop with Logos and Pathos!

I know that (might) be useful for businessIt was the beginning of November 2026, when the decline in orders for my work ...
pharmaphorum

AstraZeneca joins Tempus, Pathos in cancer AI project

AstraZeneca has started work with tech companies Tempus and Pathos AI on a project that aims to generate a wide-ranging and comprehensive generative artificial intelligence model for oncology. The ...
pharmaphorum

Pathos AI signs two cancer deals with Alphamab and AZ

Iker Huerga, Pathos AI's chief executive. Pathos AI has added to its pipeline of cancer drugs by licensing a bispecific antibody-drug conjugate (ADC) for solid tumours from China's Alphamab in a deal ...
FierceBiotech

Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug

In addition to funding its clinical work, Pathos AI stated that this morning’s series D would be used to further invest in its artificial intelligence platform ...